Technology

Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?

With a market cap of $23 billion, the company’s products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

Most Active By Dollar Volume

Data is currently not available

Most advanced

Data is currently not available

Most declined

Data is currently not available
What Catalysts Are Impacting the Top Performers in Crypto and Momentum Outlook
Andy Baehr, Head of Product at CoinDesk Indices and Elliot Chun, Partner at Architect Partners, join Jill Malandrino on Nasdaq TradeTalks to discuss what catalysts are impacting the top performers in crypto and momentum outlook.
Nov 20, 2024

Latest News in Technology

Info icon

This data feed is not available at this time.

Technology

Cryptocurrencies

Entrepreneurs

Venture Capital